Article Information
History
- July 3, 2024.
Article Versions
- Version 1 (June 13, 2024 - 06:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Suzanne E. Schindler, MD, PhD1,*,
- Kellen K. Petersen, PhD1,
- Benjamin Saef, MS1,
- Duygu Tosun, PhD2,
- Leslie M. Shaw, PhD3,
- Henrik Zetterberg, MD, PhD4,5,6,7,8,9,
- Jeffrey L. Dage, PhD10,11,
- Kyle Ferber, PhD12,
- Gallen Triana-Baltzer, PhD13,
- Lei Du-Cuny, PhD14,
- Yan Li, PhD1,
- Janaky Coomaraswamy, PhD15,
- Michael Baratta, BA, MCAHPM15,
- Yulia Mordashova, MS14,
- Ziad S. Saad, PhD13,
- David L. Raunig, PhD15,
- Nicholas J. Ashton, PhD4,16,17,
- Emily A. Meyers, PhD18,
- Carrie E. Rubel, PhD12,
- Erin G. Rosenbaugh, PhD19,
- Anthony W. Bannon, PhD20,
- William Z. Potter, MD, PhD21,
- Alzheimer’s Disease Neuroimaging Initiative (ADNI)**,
- Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team
- 1Department of Neurology, Washington University in St. Louis, 660 S. Euclid Ave., St. Louis, MO, USA 63110
- 2Department of Radiology and Biomedical Imaging, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, USA 94143
- 3Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, USA 19104
- 4Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Wallinsgatan 6, 431 41, Mölndal, Sweden
- 5Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Wallinsgatan 6, 431 41, Mölndal, Sweden
- 6UK Dementia Research Institute Fluid Biomarkers Laboratory, UK DRI at UCL, 6th Floor, Maple House, Tottenham Ct Rd, London W1T 7NF, United Kingdom
- 7Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom
- 8Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Units 1501-1502, 1512-1518, 15/F Building 17W, 17 Science Park W Ave, Science Park, Hong Kong, China
- 9Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, 600 Highland Ave J5/1 Mezzanine, Madison, WI, USA 53792
- 10Department of Neurology, Indiana University School of Medicine, 355 W 16th St Indianapolis, IN, USA 46202
- 11Stark Neurosciences Research Institute, Indiana University School of Medicine, NB Building, 320 W 15th St #414, Indianapolis, IN, USA 46202
- 12Biogen, 225 Binney St., Cambridge, MA, USA 02142
- 13Neuroscience Biomarkers, Johnson and Johnson Innovative Medicine, 3210 Merryfield Row, San Diego, CA, USA 20892
- 14AbbVie, Knollstraße 50, 67061, Ludwigshafen am Rhein, Rheinland-Pfalz, Germany
- 15Takeda Pharmaceutical Company Ltd., 650 E Kendall St., Cambridge, MA, USA 02142
- 16Banner Alzheimer’s Institute, 901 E Willetta St., Phoenix, AZ, USA 85006
- 17Banner Sun Health Research Institute, 10515 W Santa Fe Dr., Sun City, AZ, USA 85351
- 18Alzheimer’s Association, 225 N Michigan Ave., Chicago, IL, USA 60603
- 19The Foundation for the National Institutes of Health, 11400 Rockville Pike, Suite 600, North Bethesda, MD, USA 20852
- 20AbbVie, 1400 Sheridan Rd., North Chicago, IL, USA 60064
- 21Highly qualified expert
- ↵*Corresponding Author Suzanne E. Schindler, MD, PhD, Department of Neurology, Washington University School of Medicine 660 S. Euclid Avenue, Campus Box 8111, St. Louis, MO, USA 63110, E-mail: schindlers{at}neuro.wustl.edu Phone: 314-747-8423 Fax: 314-747-8427
Posted July 03, 2024.
Head-to-head comparison of leading blood tests for Alzheimer’s disease pathology
